Sorry, not following. BioAmber did buy out Mitsui, sure, and then went bankrupt after that. Just as this document explains, BioAmber is out of business, liquidated, and cash-less. The document went on to say they have no employees.
Given that to all be fact, do we still believe it is an attractive buyout candidate? (LOL!) If we do, who is negotiating this buyout on behalf of BioAmber? Don’t we think this law firm, negotiating on behalf of a segment of shareholders, would want to wait to see this $500+M buyout come to fruition instead of taking $2+M, considering the total damages were given as being greater than $35M?
